BETI-CEL

DEAD

Serial Number

79307811

Owner

bluebird bio, Inc.

Attorney

Christopher K. Albert

Filing Date

Feb 12, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BETI-CEL Trademark

Serial Number: 79307811

BETI-CEL is a trademark filed by bluebird bio, Inc. on February 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Legal Representation

Attorney of Record

Christopher K. Albert

158 trademarks filed View all →

Correspondence Address

Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.

530 Virginia Road, P.O. Box 9133

Concord, MA 01742-9133

UNITED STATES

Trademark Details

Filing Date

February 12, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances for treating genetic diseases, namely beta-thalassemia requiring regular red blood cell transfusions

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 18, 2025 ADCH

NEW REPRESENTATIVE AT IB RECEIVED

Nov 14, 2025 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Sep 13, 2024 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Jun 2, 2024 FINT

FINAL DISPOSITION NOTICE SENT TO IB

May 13, 2024 FICS

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

May 12, 2024 FICR

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 23, 2023 ADCH

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

May 12, 2023 MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

May 12, 2023 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

May 12, 2023 ABN2

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 28, 2022 GNRN

NON-FINAL ACTION E-MAILED

Oct 28, 2022 GNRT

NON-FINAL ACTION WRITTEN

Oct 28, 2022 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 29, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 28, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 28, 2022 TROA

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Sep 26, 2022 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 7, 2022 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Sep 7, 2022 OPNR

CHANGE OF NAME/ADDRESS REC'D FROM IB

Aug 26, 2022 ADCH

REFUSAL PROCESSED BY IB

May 16, 2022 RFNT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 12, 2022 GNRN

NON-FINAL ACTION E-MAILED

Apr 12, 2022 GNRT

NON-FINAL ACTION WRITTEN

Apr 12, 2022 CNRT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 11, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 11, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 11, 2022 REAP

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 11, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 10, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 10, 2022 TROA

REFUSAL PROCESSED BY IB

Oct 25, 2021 RFNT

NEW REPRESENTATIVE AT IB RECEIVED

Oct 20, 2021 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Oct 9, 2021 NREP

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 14, 2021 RFCS

REFUSAL PROCESSED BY MPU

Sep 14, 2021 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 12, 2021 RFCR

NON-FINAL ACTION WRITTEN

Sep 11, 2021 CNRT

ASSIGNED TO EXAMINER

Sep 9, 2021 DOCK

CHANGE OF OWNER RECEIVED FROM IB

Aug 13, 2021 CHLD

APPLICATION FILING RECEIPT MAILED

Apr 9, 2021 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 5, 2021 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 1, 2021 REPR

Related Trademarks

More from this Owner

G GENETIX BIOTHERAPEUTICS

GENETIX BIOTHERAPEUTICS

ZYNTEGLO

More in Same Class

GG __ 2 __ 4 __ 9

DENTAL IMMUNISATION PROGRAMME